Archive

Tag: ACTT-1

Remdesivir ACTT-1: Adaptive COVID-19 Treatment Trial Part 1

Background: The saga of Remdesivir for treatment of COVID-19 continues. We previously covered two studies of this drug on REBEL EM (Link is HERE & Link is HERE). One trial (≈200pts) showed no difference in the primary outcome of median …

Read More
Infectious Disease

Sponsored

0